A controlled study on the treatment of acute progressive cerebral infarction by continuous anticoagulation with small doses of heparin

Chinese Critical Care Medicine

Volumn 24, Issue 5, 2012, Pages 290-293

  Wang, Zhi Yong ^a   Wang, Li Chun ^a   Chen, Chao ^a   Ge, Jie Ying ^a   Gao, Yin Sheng ^a   LlN, Shu Fen ^a   Yan, Rui Ping ^a   Li, Bao Dong ^a  

^a Western Medicine of Hebei Medicine University   (China)

Author keywords

Anticoagulation; Cerebral infarction, progressive; Heparin

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE PROGRESSIVE CEREBRAL INFARCTION; ANTICOAGULATION; ARTICLE; BARTHEL INDEX; BRAIN HEMORRHAGE; BRAIN INFARCTION; CONTROLLED STUDY; ECCHYMOSIS; GINGIVA BLEEDING; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NERVE FUNCTION; OCCULT BLOOD; PARTIAL THROMBOPLASTIN TIME; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SIDE EFFECT; SUBCUTANEOUS ECCHYMOSIS;

AGED; ANTICOAGULANTS; BLOOD COAGULATION; CEREBRAL INFARCTION; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84862189508     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-0603.2012.05.009     Document Type: Article

References (15)

1. Bath PM, Lindenstrom E, Boysen G, et al. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. Lancet, 2001,358:702-710. (Pubitemid 32823398)
2. Diener HC, Ringelstein EB, von Kummer R, et al. Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the TOPAS trial. Stroke, 2001,32:22-29. (Pubitemid 32065699)
3. European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis, 2008,25:457-507.
4. Garde E, Lassen NA. Apoplexy with rapidly deteriorating symptoms - "stroke in progression", hemodynamic and clinical aspects. Ugeskr Laeger, 1995,157:4234-4239.
5. International Stroke Trial Collaborative Group. The International Stroke Trial (1ST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet, 1997,349:1569-1581.
6. Zabel KM, Granger CB, Becker RC, et al. Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I: global utilization of streptokinase and TPA for occluded coronary arteries. Am Heart J, 1998,136:868-876. (Pubitemid 28506888)
7. Tong DC, Adami A, Moseley ME, et al. Relationship between apparent diffusion coefficient and subsequent hemorrhagic transformation following acute ischemic stroke. Stroke, 2000,31:2378-2384.
8. Chamorro A. Heparin in acute ischemic stroke: the case for a new clinical trial. Cerebrovasc Dis, 1999,9 Suppl 3:16-23. (Pubitemid 29373877)